Back to REGN
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA → REGN
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$76K
Q3 2026
Peak value
$67M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $67M |
| Q4 2025 | $77K |
| Q1 2026 | $54.2M |
| Q1 2026 | $75K |
| Q2 2026 | $41M |
| Q2 2026 | $62K |
| Q3 2026 | $30.1M |
| Q3 2026 | $76K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $76K | 100 | — | — |
| Q3 2026 | $30.1M | 39.7K | — | — |
| Q2 2026 | $62K | 100 | — | — |
| Q2 2026 | $41M | 65.8K | — | — |
| Q1 2026 | $75K | 100 | — | — |
| Q1 2026 | $54.2M | 72.3K | — | — |
| Q4 2025 | $77K | 100 | — | — |
| Q4 2025 | $67M | 86.9K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B